Last Updated: June 25, 2026

Claims for Patent: 10,934,341

✉ Email this page to a colleague

Summary for Patent: 10,934,341

Title:	Albumin variants
Abstract:	The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Inventor(s):	Jason Cameron, Karen Ann Delahay, Jens Erik Nielsen, Andrew Plumridge, Jan Terje Andersen
Assignee:	Sartorius Albumedix Ltd , Novozymes Biopharma DK AS
Application Number:	US16/598,939

Details for Patent 10,934,341

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Kedrion, S.p.a.	KEDBUMIN	albumin (human)	Injection	125384	June 03, 2011	10,934,341	2039-10-10
Kedrion, S.p.a.	KEDBUMIN	albumin (human)	Injection	125384	September 05, 2013	10,934,341	2039-10-10
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,934,341

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2013343503	⤷ Start Trial
Australia	2018201136	⤷ Start Trial
Brazil	112015010318	⤷ Start Trial
Canada	2890766	⤷ Start Trial
China	105452290	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.